Application 216229

Type
ANDA
Sponsor
ANNORA PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DEFERASIROXDEFERASIROXGRANULE;ORAL180MGNoNo
002DEFERASIROXDEFERASIROXGRANULE;ORAL360MGNoNo
003DEFERASIROXDEFERASIROXGRANULE;ORAL90MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
31722-030DEFERASIROXDEFERASIROXCamber Pharmaceuticals, Inc.ANDACurrent
31722-031DEFERASIROXDEFERASIROXCamber Pharmaceuticals, Inc.ANDACurrent